6. Randomised controlled trial

26
KNOWLEDGE FOR THE BENEFIT OF HUMANITY KNOWLEDGE FOR THE BENEFIT OF HUMANITY PUBLIC HEALTH AND EPIDEMIOLOGY (HFS3063) Epidemiological Study Designs: RANDOMISED CONTROLLED TRIALS Dr. Dr. Mohd Mohd Razif Razif Shahril Shahril School of Nutrition & Dietetics School of Nutrition & Dietetics Faculty of Health Sciences Faculty of Health Sciences Universiti Universiti Sultan Sultan Zainal Zainal Abidin Abidin 1

Transcript of 6. Randomised controlled trial

KNOWLEDGE FOR THE BENEFIT OF HUMANITYKNOWLEDGE FOR THE BENEFIT OF HUMANITY

PUBLIC HEALTH AND EPIDEMIOLOGY (HFS3063) Epidemiological Study Designs:

RANDOMISED CONTROLLED TRIALS

Dr. Dr. MohdMohd RazifRazif ShahrilShahril

School of Nutrition & Dietetics School of Nutrition & Dietetics

Faculty of Health SciencesFaculty of Health Sciences

UniversitiUniversiti Sultan Sultan ZainalZainal AbidinAbidin

1

Topic Learning Outcomes

By the end of this lecture, students should be able to;

• describe randomised controlled trial design.

• explain the advantages and disadvantages of randomised controlled trial design.

2

Randomized controlled trials (RCT)

• RCT or randomized clinical trials are experimental

studies where the effect of an intervention is assessed

by collecting data before and after an intervention.

• Used to compare an intervention with one or more other

intervention or with no intervention.

• Intervention are often clinical treatments but may also be

educational interventions (e.g. health promotion leaflets).

• Two main features of the RCT;

a) They are comparative

b) They are designed to minimize bias

3

a) Comparative

• In RCT, an intervention is investigated by comparing one

group of people who receive the intervention with a

control group or control arm who do not.

• Control group receives usual or no treatment and their

outcome measure (or the change in measure from the

baseline) is compared with that of the intervention group.

4

5

b) Minimizing bias in RCT

1) Allocation bias

2) Performance bias

3) Assessment bias

4) Attrition bias

5) Allocation concealment

6

1) Allocation bias

• Occurs when the measured treatment effect differs from

the true treatment effect because of how participants

were selected into the intervention or control group.

• In RCT, participants will be randomized to either an

intervention or control group at study entry.

• Randomization ensures that characteristics that might

affect the relationship between intervention and outcome

measures will be roughly equal across all arms of the

study

– minimizing potential bias

7

2) Performance bias

• Occurs when participants’ response to the treatment is

affected by knowledge of the group to which they are

assigned.

– They know which group they belongs to either intervention or

control.

• Performance bias might also occur when health

professionals administer treatment differently

between treatment arms.

8

3) Assessment bias

• Health professionals assessing the outcome of treatment

relative to alternative or placebo interventions may

record outcome measures biased by the knowledge of

the group assignments.

• Overestimation or underestimation of the effects on

an intervention is known as assessment bias.

• There might be a systematic difference in measuring

the outcomes between the two groups because of the

method of recording used

– E.g. control group is assigned to one practitioner and the

intervention group to another, or groups are assessed at different

times of the day.

9

(cont.) 3) Assessment bias

• How to minimize the assessment bias?

– Use a standardized method of evaluation across both groups.

– Avoid using subjective measures to assess the effectiveness

of a treatment which are more prone to bias.

10

4) Attrition bias

• Also called as loss-to-follow-up bias.

• Occurs when patients drop out of the study from their

respective study group.

• If halfway through a study the treatment has been

successful, participants may drop out and information

about the success of the treatment is then lost.

• Participants in the control group might be unhappy with

their lack of progress and may drop out of the study in

order to seek alternative help.

11

5) Allocation concealment

• Bias will be minimized where the allocation schedule is concealed of whom is assigned to which group.

• Blinding (or masking) helps prevent systematic differences between comparison groups in prognosis or responsiveness to treatments (allocation bias).

• Blinding of both participants and practitioners prevents performance and assessment bias by ensuring everybody (participants, treatment admin, those measuring outcomes) do not know which treatment was given.

• It is recommended RCT participants are blind to the treatment they receive. – Control group receives placebo

12

Why carry out RCT?

• RCT are prospective longitudinal studies

– Allowing causal association between intervention and outcomes.

• The random selection of participants into each arm and

the controlled way in which trial is carried out mean that

all factors are considered equal.

• Other study design cannot infer causality.

13

Important factors in RCT?

1) Sample size

2) Stratification

3) Trial design

4) Between group contamination

5) Ethical issues

14

1) Sample size

• Sample size dependent upon

– the power of the test

– what size of intervention impact is considered meaningful

– type of hypothesis the RCT is testing

• The smaller magnitude of difference between groups

that is to be detected and the greater the variability in

outcomes, the larger the sample size that will be

required.

15

2) Stratification

• Very large trials are likely to have a good balance of

patients within each arm.

• When samples are small, however, treatment groups

may be chance end up with different characteristics

– May affect the outcome trial

• Stratification is a way of ensuring the treatment groups

are balanced on characteristics that are likely to alter the

relationship between treatment and outcome.

16

3) Trial design

• There are two commonly used trial design to allocate

treatment and control regimens in RCT;

– Parallel design

– Crossover design

• In parallel design, different patients will be randomized in

each treatment group.

– There will be differences in characteristics of participants

17

(cont.) 3) Trial design

• Crossover trials are another way of overcoming

differences in groups by keeping the patients as

matched as possible.

• Instead of having different patients in each treatment

group, patients receive first one treatment and then the

other, in random order, with a wash out period in

between.

18

(cont.) 3) Trial design

• Within-patient differences are then compared in

crossover design.

• Each patient effectively becomes their own ‘test’ and

‘control’.

19

4) Between group contamination

• Educational interventions are prone to contamination

e.g. a member of the control arm is a friend of a patient

receiving the low fat diet advice intervention.

– Information will be passed between the two arms of trial and thus

alter results.

• Use cluster sampling so natural cluster such as

geographic areas are randomized rather than

individuals.

20

5) Ethical issues

• RCT is not always possible because of ethical issues

when assigning patients to study arms.

• If one group of patients receives treatment thought to be

effective, while another group does not, the ethics of a

trial may be brought into question.

• Similarly, there are some trials that cannot be carried out

because they may actively encourage unhealthy

practices e.g. smoking.

– People cannot be randomized into smoking and non-smoking

group.

21

Analysis of data

• RCT are experiments set up to test hypotheses.

• Null hypotheses – the intervention will have no impact on

the outcome measure

– Outcome will be similar in both the test and control groups

• Alternative hypotheses – intervention will have

meaningful effect and statistically significant

• Statistical method (e.g.);

– Pre and post intervention differences = paired t-test

– Mean differences pre and post between two group =

independent t-test

– Mean differences pre and post between more than two groups =

ANOVA

22

Advantages of RCT

• Ability to make causal inferences mean that RCT provide

the strongest empirical evidence of a treatment’s

efficacy.

• Randomization of participants to the test and control

arms and concealment of their allocation ensures that

allocation bias and confounding or unknown variables

are minimized.

• The study can be tailored to answer a specific question.

23

Disadvantages of RCT

• High dropout when the intervention has undesirable

side-effects or there is little incentive to stay in the

control arm.

• Ethical consideration may mean that a research question

cannot be investigated using RCT design

• For a descriptive overview it may be cheaper and easier

to use an observational design.

• Prior knowledge is required for sample size calculation;

– the level of improvement that is clinically meaningful

– expected variation of improvement in the sample

24

Recapitulate In this lecture, you have been exposed to;

• definition of RCT

• how biases is minimized in RCT

• factors to be considered when carrying out RCT

• analysis of data for RCT

• advantages and disadvantages of RCT

25

Thank YouThank You

26